Edition:
United Kingdom

Editas Medicine Inc (EDIT.OQ)

EDIT.OQ on NASDAQ Stock Exchange Global Select Market

25.76USD
17 Sep 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$25.76
Open
$25.78
Day's High
$26.09
Day's Low
$25.54
Volume
141,396
Avg. Vol
221,658
52-wk High
$33.79
52-wk Low
$17.90

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Jun '19 2.33 -0.689
Mar '19 2.07 -0.599
FY 2018 Dec '18 6.12 -0.522
Sep '18 14.52 -0.321
Jun '18 7.37 -0.825
Mar '18 3.93 -0.673
FY 2017 Dec '17 3.67 -0.849
Sep '17 6.28 -0.644
Jun '17 3.10 -0.648
Mar '17 0.68 -0.852
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 6 4.72 8.80 2.00 9.47
Quarter Ending Dec-19 6 5.77 8.80 2.00 15.13
Year Ending Dec-19 7 19.03 39.03 8.40 31.06
Year Ending Dec-20 8 24.30 41.40 7.53 30.01
Earnings (per share)
Quarter Ending Sep-19 7 -0.72 -0.67 -0.79 -0.86
Quarter Ending Dec-19 7 -0.76 -0.68 -0.89 -1.00
Year Ending Dec-19 7 -2.75 -2.64 -2.84 -3.31
Year Ending Dec-20 8 -3.00 -2.68 -3.36 -3.54
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.39 32.66
P/E High - Last 5 Yrs. -- 147.53 47.31
P/E Low - Last 5 Yrs. -- 47.83 23.88
Beta -- 1.08 0.89
Price to Sales (TTM) 185.11 49.44 7.91
Price to Book (MRQ) 5.53 10.14 5.38
Price to Tangible Book (MRQ) 5.64 13.75 6.71
Price to Cash Flow (TTM) -- 55.95 24.36
% Owned Institutions 85.00 3.66 1.45

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.35
Dividend Yield - 5 Year Avg -- 0.09 1.38
Dividend 5 Year Growth Rate -- 0.78 4.54
Payout Ratio(TTM) -- 7.01 40.24

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -8.59 205.58 12.23
Sales (TTM) vs TTM 1 Yr. Ago -0.28 49.07 7.74
Sales - 5 Yr. Growth Rate -- 22.80 10.88
EPS (MRQ) vs Qtr. 1 Yr. Ago -19.99 76.36 42.97
EPS (TTM) vs TTM 1 Yr. Ago -67.60 -- --
EPS - 5 Yr. Growth Rate -- 11.92 10.31
Capital Spending - 5 Yr. Growth Rate -- 9.20 14.84

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.23 2.21
Current Ratio (MRQ) 6.73 3.59 3.03
LT Debt to Equity (MRQ) 18.31 18.57 10.20
Total Debt to Equity (MRQ) 26.42 31.19 14.55
Interest Coverage (TTM) -- -44.62 29.80

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.09 52.24
Gross Margin - 5 Yr. Avg. -- 60.28 50.41
EBITD Margin (TTM) -2,036.53 -- --
EBITD - 5 Yr. Avg -- -110.43 13.12
Operating Margin (TTM) -2,072.90 -183.67 6.81
Operating Margin - 5 Yr. Avg. -- -126.86 8.92
Pre-Tax Margin (TTM) -2,091.36 -174.38 5.99
Pre-Tax Margin - 5 Yr. Avg. -- -132.62 9.22
Net Profit Margin (TTM) -2,091.36 -181.07 2.63
Net Profit Margin - 5 Yr. Avg. -- -136.99 5.58
Effective Tax Rate (TTM) -- 22.42 22.40
Effective Tax Rate - 5 Yr. Avg. -- 15.43 22.75

Efficiency

  Company industry sector
Revenue/Employee (TTM) 63,360 7,668,778 887,293,250
Net Income/Employee (TTM) -1,325,079 533,004 101,845,265
Receivable Turnover (TTM) 5.60 6.23 5.93
Inventory Turnover (TTM) -- 1.88 3.36
Asset Turnover (TTM) 0.02 0.32 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -38.14 6.40 11.17
Return on Assets - 5 Yr. Avg. -- 5.50 12.34
Return on Investment (TTM) -42.42 8.95 14.48
Return on Investment - 5 Yr. Avg. -- 6.82 16.02
Return on Equity (TTM) -63.35 10.09 15.78
Return on Equity - 5 Yr. Avg. -- 8.46 17.01
  1 Year 3 Year 5 Year
Sales % 271.58 -- --
EPS (TTM) % -46.99 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Editas Medicine Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 24.49 20.20 99 98
13 Week 45.58 38.49 99 95
26 Week 19.67 10.57 99 97
52 Week 66.62 41.23 99 71
YTD 54.10 35.33 99 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 81.56%
# of Holders: 263
Total Shares Held: 40,385,715
3 Mo. Net Change: 1,241,436
# New Positions: 33
# Closed Positions: 37
# Increased Positions: 112
# Reduced Positions: 101
# Net Buyers: 11
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.